[September 24, 2018]

COCRYSTAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Cocrystal Pharma, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cocrystal Pharma, Inc. ("Cocrystal" or the "Company") (NASDAQ:COCP) f/k/a BioZone Pharmaceuticals, Inc. ("BioZone").

If you invested in Cocrystal or BioZone stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/COCPThere is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected].

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180924006021/en/

[ Back To TMCnet.com's Homepage ]